Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2014 1
2015 4
2017 2
2018 5
2019 2
2020 11
2021 4
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC; PIONEER 6 Investigators. Husain M, et al. N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11. N Engl J Med. 2019. PMID: 31185157 Clinical Trial.
Fracture fixation in the operative management of hip fractures (FAITH): an international, multicentre, randomised controlled trial.
Fixation using Alternative Implants for the Treatment of Hip fractures (FAITH) Investigators. Fixation using Alternative Implants for the Treatment of Hip fractures (FAITH) Investigators. Lancet. 2017 Apr 15;389(10078):1519-1527. doi: 10.1016/S0140-6736(17)30066-1. Epub 2017 Mar 3. Lancet. 2017. PMID: 28262269 Free PMC article. Clinical Trial.
Study Summaries.
FAITH Investigators; HEALTH Investigators. FAITH Investigators, et al. J Orthop Trauma. 2020 Nov;34 Suppl 3:Sii-Siii. doi: 10.1097/BOT.0000000000001927. J Orthop Trauma. 2020. PMID: 33027158 No abstract available.
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern.
Li W, Chen Y, Prévost J, Ullah I, Lu M, Gong SY, Tauzin A, Gasser R, Vézina D, Anand SP, Goyette G, Chaterjee D, Ding S, Tolbert WD, Grunst MW, Bo Y, Zhang S, Richard J, Zhou F, Huang RK, Esser L, Zeher A, Côté M, Kumar P, Sodroski J, Xia D, Uchil PD, Pazgier M, Finzi A, Mothes W. Li W, et al. bioRxiv. 2021 Aug 3:2021.08.02.454546. doi: 10.1101/2021.08.02.454546. Preprint. bioRxiv. 2021. PMID: 34373853 Free PMC article. Updated.
Here we elucidate the structural basis and mode of action for two potent SARS-CoV-2 Spike (S) neutralizing monoclonal antibodies CV3-1 and CV3-25 that remained effective against emerging variants of concern in vitro and in vivo. ...
Here we elucidate the structural basis and mode of action for two potent SARS-CoV-2 Spike (S) neutralizing monoclonal antibodies CV3- …
Are large clinical trials in orthopaedic trauma justified?
Sprague S, Tornetta P 3rd, Slobogean GP, O'Hara NN, McKay P, Petrisor B, Jeray KJ, Schemitsch EH, Sanders D, Bhandari M; FLOW Investigators. Sprague S, et al. BMC Musculoskelet Disord. 2018 Apr 20;19(1):124. doi: 10.1186/s12891-018-2029-3. BMC Musculoskelet Disord. 2018. PMID: 29678204 Free PMC article.
Deaths and Years of Potential Life Lost From Excessive Alcohol Use - United States, 2011-2015.
Esser MB, Sherk A, Liu Y, Naimi TS, Stockwell T, Stahre M, Kanny D, Landen M, Saitz R, Brewer RD. Esser MB, et al. MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):981-987. doi: 10.15585/mmwr.mm6930a1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32730240 Free PMC article. Corrected and republished.
CDC used the Alcohol-Related Disease Impact (ARDI) application* to estimate national and state average annual alcohol-attributable deaths and years of potential life lost (YPLL) during 2011-2015, including deaths from one's own excessive drinking (e.g., liver disease) and …
CDC used the Alcohol-Related Disease Impact (ARDI) application* to estimate national and state average annual alcohol-attributable deaths an …
Deaths and Years of Potential Life Lost From Excessive Alcohol Use - United States, 2011-2015.
Esser MB, Sherk A, Liu Y, Naimi TS, Stockwell T, Stahre M, Kanny D, Landen M, Saitz R, Brewer RD. Esser MB, et al. MMWR Morb Mortal Wkly Rep. 2020 Oct 2;69(39):1428-1433. doi: 10.15585/mmwr.mm6939a6. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33001874 Free PMC article.
CDC used the Alcohol-Related Disease Impact (ARDI) application* to estimate national and state average annual alcohol-attributable deaths and years of potential life lost (YPLL) during 2011-2015, including deaths from one's own excessive drinking (e.g., liver disease) and …
CDC used the Alcohol-Related Disease Impact (ARDI) application* to estimate national and state average annual alcohol-attributable deaths an …
29 results